Literature DB >> 9836594

The N-terminal domain of human topoisomerase IIalpha is a DNA-dependent ATPase.

L P Gardiner1, D I Roper, T R Hammonds, A Maxwell.   

Abstract

We have constructed clones encoding N-terminal fragments of human DNA topoisomerase IIalpha. We show that the N-terminal domain (approximately 50 kDa) has an intrinsic ATPase activity that can be stimulated by DNA. The enzyme obeys Michaelis-Menten kinetics showing a approximately 6-fold increase in kcat in the presence of DNA. Cross-linking studies indicate that the N-terminal domain is a dimer in the absence and presence of nucleotides. Using site-directed mutagenesis, we have identified the catalytic residue for ATP hydrolysis as Glu86. Phosphorylation of the N-terminal domain with protein kinase C does not affect the ATPase activity. The ATPase domain of human topoisomerase IIalpha shows significant differences from its counterpart in DNA gyrase and we discuss the mechanistic implications of these data.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836594     DOI: 10.1021/bi9818321

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Dynamics of strand passage catalyzed by topoisomerase II.

Authors:  Ping Xie
Journal:  Eur Biophys J       Date:  2010-02-03       Impact factor: 1.733

2.  Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Aditi Das; Chhabinath Mandal; Rakhee Das; Tanmoy Mukherjee; Hemanta K Majumder
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 3.  Intronic Polyadenylation in Acquired Cancer Drug Resistance Circumvented by Utilizing CRISPR/Cas9 with Homology-Directed Repair: The Tale of Human DNA Topoisomerase IIα.

Authors:  Terry S Elton; Victor A Hernandez; Jessika Carvajal-Moreno; Xinyi Wang; Deborah Ipinmoroti; Jack C Yalowich
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

4.  Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187.

Authors:  Scott Classen; Stephane Olland; James M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

5.  Coupling between ATP binding and DNA cleavage by DNA topoisomerase II: A unifying kinetic and structural mechanism.

Authors:  Felix Mueller-Planitz; Daniel Herschlag
Journal:  J Biol Chem       Date:  2008-04-10       Impact factor: 5.486

6.  mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activity.

Authors:  Kathryn L Gilroy; Chrysoula Leontiou; Kay Padget; Jeremy H Lakey; Caroline A Austin
Journal:  Nucleic Acids Res       Date:  2006-03-20       Impact factor: 16.971

7.  Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Rakhee Das; Aditi Das; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2005-04-28       Impact factor: 16.971

8.  Catalytic Mechanism of ATP Hydrolysis in the ATPase Domain of Human DNA Topoisomerase IIα.

Authors:  Mitja Ogrizek; Matej Janežič; Katja Valjavec; Andrej Perdih
Journal:  J Chem Inf Model       Date:  2022-08-10       Impact factor: 6.162

9.  Binding of two DNA molecules by type II topoisomerases for decatenation.

Authors:  Rupesh Kumar; Jane E Riley; Damian Parry; Andrew D Bates; Valakunja Nagaraja
Journal:  Nucleic Acids Res       Date:  2012-09-18       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.